Methods for Claims-Based Pharmacoeconomic Studies in Psychosis
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 20 (8) , 499-511
- https://doi.org/10.2165/00019053-200220080-00001
Abstract
Pharmacoeconomic studies using claims data are frequently employed to compare the healthcare costs associated with competing drugs. Different methodological approaches with varying limitations for...Keywords
This publication has 28 references indexed in Scilit:
- Using Healthcare Claims Data for Outcomes Research and Pharmacoeconomic AnalysesPharmacoEconomics, 1999
- Methodological Hurdles in Conducting Pharmacoeconomic AnalysesPharmacoEconomics, 1999
- The use of claims databases for outcomes research: rationale, challenges, and strategiesClinical Therapeutics, 1997
- Guidelines for Pharmacoeconomic StudiesPharmacoEconomics, 1997
- Problems in conducting economic evaluations alongside clinical trialsThe British Journal of Psychiatry, 1997
- Practical issues in conducting pharmacoeconomic studiesClinical Therapeutics, 1996
- Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic TherapyClinical Drug Investigation, 1996
- Efficacy and safety of risperidone in the long-term treatment of patients with schizophreniaClinical Therapeutics, 1995
- Cost-effectiveness comparisons using “real world” randomized trials: The case of new antidepressant drugsJournal of Clinical Epidemiology, 1995
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991